Guardant Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Guardant Health, Inc. on June 13, 2019, covering events occurring on June 11, 2019. The Company is an emerging growth company incorporated in Delaware, with its principal executive offices in Redwood City, California. Its common stock trades on The Nasdaq Stock Market LLC under the symbol "GH".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance event and does not contain financial performance data.
Material Changes
The material change reported is the departure of a senior executive:
- Individual: Leena Das-Young, Pharm. D.
- Role: Chief LUNAR Officer and General Manager.
- Reason: Personal reasons.
- Effective Date: June 11, 2019 (announcement); service continues through June 18, 2019.
Guidance, Outlook, and Management Commentary
The filing contains no guidance, outlook, or general management commentary regarding future business performance. Regarding the executive departure, the Company noted that Dr. Das-Young will receive benefits under the Executive Severance Plan and retain certain relocation benefits in exchange for a customary release of claims.
Investor Verification Checklist
- Confirm the timeline for the transition of duties following Dr. Das-Young's departure on June 18, 2019.
- Review the Company's Executive Severance Plan to understand the specific financial implications of the departure.
- Monitor subsequent filings for the appointment of a successor to the Chief LUNAR Officer and General Manager roles.